Tech Convergence, Quality Data Needed To Accelerate Korea’s AI-Powered R&D
Players Still ‘Fragmented And Segmented’
AI-powered drug development was a major topic at the recent Bio Korea meeting, where experts discussed how the technology is changing R&D activities and the challenges being faced by Korean firms as they look to catch up with their global competitors.
